ASX:XRO
ASX:XROSoftware

Xero (ASX:XRO): Assessing Valuation After Strong ASX 200 Performance and Digital Transformation Gains

Recent coverage has drawn attention to Xero (ASX:XRO) and its sustained performance within the ASX 200. It highlights both its consistent market fundamentals and its impact on digital transformation for Australian small and medium businesses. See our latest analysis for Xero. After a strong year of innovation and sustained relevance within the ASX 200, Xero’s share price has eased to A$145.98, with recent volatility, such as a -5.07% slide over the last week and a -9.3% dip for the month,...
ASX:CLV
ASX:CLVChemicals

Clover And 2 Other ASX Penny Stocks To Watch

With the Reserve Bank's recent decision to hold interest rates steady and earnings season concluded, Australian shares are experiencing a period of uncertainty, with the ASX 200 attempting to rebound from a six-week low. In this context, penny stocks—though an older term—remain relevant for investors seeking opportunities in smaller or emerging companies that may offer growth potential. By focusing on those with solid financial health and clear growth prospects, investors can uncover...
ASX:SUL
ASX:SULSpecialty Retail

Super Retail Group (ASX:SUL): Valuation Insights Following New CEO Appointment and Leadership Transition

Super Retail Group (ASX:SUL) has named Paul Bradshaw as its next CEO, effective November 1, 2025, following the recent departure of its previous chief executive due to governance issues. Bradshaw’s three decades of retail leadership could signal a stable transition for investors. See our latest analysis for Super Retail Group. Super Retail Group’s leadership updates come on the heels of a solid long-term run for investors. The total shareholder return over the past year stands at 17%, and an...
ASX:TLX
ASX:TLXBiotechs

Telix Pharmaceuticals (ASX:TLX): Examining Valuation After SEC Subpoena and Ongoing Legal Probes

Telix Pharmaceuticals (ASX:TLX) has disclosed that it received a subpoena from the U.S. Securities and Exchange Commission regarding statements about its prostate cancer therapeutics. This has prompted several law firms to investigate possible securities violations. See our latest analysis for Telix Pharmaceuticals. The pressure from regulatory scrutiny and legal investigations has weighed on Telix Pharmaceuticals’ momentum, with the share price dropping 33.9% year-to-date and the 1-year...
ASX:LYC
ASX:LYCMetals and Mining

Lynas Rare Earths (ASX:LYC) Is Down 12.4% After Revenue Jump Misses Estimates – Has The Bull Case Changed?

In late October 2025, Lynas Rare Earths reported first-quarter results showing a 66% increase in revenue to A$200.2 million, fueled by higher demand for rare earths and enhanced production capacity, though the result came in below analyst estimates. The company advanced its global supply chain presence by signing new offtake agreements, accelerating heavy rare earth output, and securing capital for growth, as Western nations sought alternatives to China's supply dominance. We'll explore how...
ASX:ING
ASX:INGFood

Inghams Group (ASX:ING) Valuation Perspective Following Share Price Slide and Turnaround Moves

Inghams Group (ASX:ING) is navigating a rough patch, with its share price falling sharply as the company grapples with declining poultry volumes, revenue, and profit. The drop has prompted swift action on multiple operational fronts. See our latest analysis for Inghams Group. Inghams Group’s share price has lost considerable ground this year, sliding to A$2.39 and notching a 90-day price return of -29.5% as the company faces operational headwinds. While short-term momentum is fading, the...
ASX:ALK
ASX:ALKMetals and Mining

Alkane Resources (ASX:ALK): Evaluating Valuation After Strong 12-Month Share Price Rally

Alkane Resources (ASX:ALK) has delivered a sharp turnaround over the past year, catching the attention of market watchers. Shares have climbed nearly 90% in 12 months, reflecting strong momentum and shifting investor sentiment. See our latest analysis for Alkane Resources. Momentum around Alkane Resources has intensified lately, with the company’s latest 90-day share price return of nearly 33% highlighting renewed optimism following last year's breakout. While its one-year total shareholder...
ASX:NST
ASX:NSTMetals and Mining

Northern Star Resources (ASX:NST): Evaluating Valuation After Quarterly Results and Forward Guidance Reaffirmation

Northern Star Resources (ASX:NST) released its first quarter results, selling 381,000 ounces of gold at an all-in sustaining cost of A$2,522 per ounce. The company also reaffirmed its guidance for fiscal year 2026. See our latest analysis for Northern Star Resources. After a year of sustained momentum, Northern Star Resources has seen its share price climb 54.8% year-to-date, with a three-year total shareholder return of 175.6% highlighting steady outperformance. This recent rally suggests...
ASX:CIA
ASX:CIAMetals and Mining

Champion Iron (ASX:CIA) Valuation in Focus Following Strong Q2 Earnings and Dividend Announcement

Champion Iron (ASX:CIA) just announced its second quarter earnings, revealing sharp growth in sales and net income from a year earlier, and declared a semi-annual dividend. This news has caught the attention of many investors. See our latest analysis for Champion Iron. Positive momentum is clearly building for Champion Iron, with the latest results and dividend likely sparking increased interest from investors. After sliding earlier in the year, the stock’s 14.7% jump over the past week and...